Among these comparisons, MLL-rearranged AML proved to be the most highly anti-concordant to MBNL1 knockdown, with non-MLL rearanged MBNL1 knockdown (in K562 cells) among the most concordant (Fig. 6f; Supplementary Data 2). This evidence concerns the gene MBNL1 and acute myeloid leukemia.